Expanding the Tyrosine Kinase Domain of CSF1R ? A Case Report From an Adult‐Onset Leukoencephalopathy
American Journal of Medical Genetics Part A · 2025
DOI: 10.1002/ajmg.a.64065 ↗Kurz gefasst
Fallbericht in der Zeitschrift American Journal of Medical Genetics Part A, 2025. Verfasst von Piervito Lopriore und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical and Experimental Medicine, Neurological Institute, University of Pisa, Pisa, Italy. Hauptthemen laut MEDLINE: Leukoencephalopathies, Receptors, Granulocyte-Macrophage Colony-Stimulating Factor, Protein-Tyrosine Kinases. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero dell'Istruzione, dell'Università e della Ricerca, Telethon-MITOCON, European Union - Next-GenerationEU - National Recovery and Resilience Plan (NRRP).
Abstract (Originalsprache)
Adult‐onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP), also termed hereditary diffuse leukoencephalopathy with spheroids‐1 (HDLS1), results from mutations in the CSF1R gene and leads to progressive leukoencephalopathy. This autosomal dominant condition typically manifests in the fourth or fifth decade of life with a combination of early‐onset dementia, neuropsychiatric changes, and motor symptoms. CSF1R mutations are predominantly located within the tyrosine kinase domain (TKD) of the protein, crucial for its kinase activity. However, variants outside the TKD can also disrupt kinase function. Here, we report a 58‐year‐old man with early‐onset dementia and a novel missense variant [c.1735C>G, p.(Arg579Gly)] just outside the TKD of CSF1R . Functional analysis showed impaired autophosphorylation of the mutant protein, supporting its pathogenicity. This case highlights the importance of functional validation in newly identified CSF1R variants, underscoring the need for comprehensive genetic and functional analysis in diagnosing and understanding this rare neurological disorder.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical and Experimental Medicine, Neurological Institute, University of Pisa, Pisa, Italy.
- Scuola Superiore Sant'Anna, Ph.D. School in Translational Medicine, Pisa, Italy.
- Neuroradiology Unit, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.
- Department of Life Sciences, National Chung Hsing University, Taichung, Taiwan.
- The iEGG and Animal Biotechnology Research Center, National Chung Hsing University, Taichung, Taiwan.
- Laboratory of Molecular Genetics, University Hospital of Pisa, Pisa, Italy.
ORCID-Profile: Piervito Lopriore, Michelangelo Mancuso
Förderung
- Ministero dell'Istruzione, dell'Università e della Ricerca
- Telethon-MITOCON
- European Union - Next-GenerationEU - National Recovery and Resilience Plan (NRRP)
- European Joint Program on Rare Diseases
- Ministry of Education, University and Research
Zitieren
APA
Lopriore, P., Migaleddu, G., Tsai, P. C., Fogli, A., Caligo, M. A., Siciliano, G., Cosottini, M., Lee, Y. C., Liao, Y. C., Mancuso, M., Ceravolo, R., & Frosini, D. (2025). Expanding the Tyrosine Kinase Domain of CSF1R ? A Case Report From an Adult‐Onset Leukoencephalopathy. American Journal of Medical Genetics Part A. https://doi.org/10.1002/ajmg.a.64065
Vancouver
Lopriore P, Migaleddu G, Tsai PC, Fogli A, Caligo MA, Siciliano G, et al. Expanding the Tyrosine Kinase Domain of CSF1R ? A Case Report From an Adult‐Onset Leukoencephalopathy. American Journal of Medical Genetics Part A. 2025. doi:10.1002/ajmg.a.64065
BibTeX
@article{Lopriore2025,
author = {Lopriore, Piervito and Migaleddu, Gianmichele and Tsai, Pei-Chien and Fogli, Antonella and Caligo, Maria Adelaide and Siciliano, Gabriele and Cosottini, Mirco and Lee, Yi-Chung and Liao, Yi-Chu and Mancuso, Michelangelo and Ceravolo, Roberto and Frosini, Daniela},
title = {Expanding the Tyrosine Kinase Domain of CSF1R ? A Case Report From an Adult‐Onset Leukoencephalopathy},
journal = {American Journal of Medical Genetics Part A},
year = {2025},
doi = {10.1002/ajmg.a.64065}
}
EUVIMED